Mahendra Shah, MD
Psychiatry · Lawrenceville, GANPI 1326122367
Payments from drug & device makers
Across 208 payments — averaging $29.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- AbbVie$886
- Johnson & Johnson$514
- Neurocrine Biosciences, Inc.$386
- Alkermes, Inc.$371
- Otsuka America Pharmaceutical, Inc.$356
- plus $2K from 18 others
What the payments were for
- Speaking & faculty fees$1,52025%
- Travel & lodging$210%
- Food & beverage$4,64875%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $1,884 |
| AbbVie(2 entities) | 41 | $886 |
| Johnson & Johnson | 16 | $514 |
| Neurocrine Biosciences, Inc. | 15 | $386 |
| Alkermes, Inc. | 10 | $371 |
| Otsuka America Pharmaceutical, Inc. | 16 | $356 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $316 |
| Teva Pharmaceuticals USA, Inc. | 9 | $239 |
| Supernus Pharmaceuticals, Inc. | 10 | $232 |
| Vanda Pharmaceuticals Inc. | 9 | $207 |
| Tris Pharma Inc | 6 | $182 |
| Sunovion Pharmaceuticals Inc. | 1 | $125 |
| Corium, LLC | 7 | $122 |
| Lundbeck LLC | 4 | $69 |
| Neos Therapeutics, LP | 4 | $67 |
| E.r. Squibb & Sons, L.L.C. | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 3 | $41 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINTELLIX$1,320
- ARISTADA$480
- VRAYLAR$251
- VIIBRYD$200
- LATUDA$125
- ARISTADA INITIO$120
- CAPLYTA$113
- Austedo XR$111
- INVEGA SUSTENNA$106
- INVEGA TRINZA$106
How this compares
$6,188 in reported general payments places this provider in the 85th percentile of 900 psychiatry providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 150 | $4,795 |
| Duloxetine Hcl | 214 | $4,137 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 72 | $3,539 |
| Bupropion XlBupropion Hcl | 171 | $3,007 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 103 | $2,780 |
| Trazodone Hcl | 314 | $2,362 |
| Paliperidone ErPaliperidone | 20 | $1,894 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 123 | $1,608 |
| Lamotrigine | 186 | $1,521 |
| Ziprasidone Hcl | 28 | $1,463 |
| Atomoxetine Hcl | 18 | $1,171 |
| Escitalopram Oxalate | 112 | $1,054 |
| Fluoxetine Hcl | 127 | $983 |
| Quetiapine Fumarate | 91 | $983 |
| Buspirone Hcl | 73 | $882 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lawrenceville
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Maria JohnsonDecatur$5.4M
- Bethany DavisAtlanta$4.4M
- Michael BanovMarietta$4.2M
- Michael MobleySavannah$2.9M
- Richard PettyLoganville$2.9M
- Felipe SuplicyRome$2.3M
- Angelo SambunarisAlpharetta$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.